Group IIC self-splicing intron-derived novel circular RNA vaccine elicits superior immune response against RSV
The development of the novel circular RNA vaccine platform holds significant promise for advancing next-generation therapeutics for disease treatment and prevention.
Authors
- Wei Peng (ORCID: https://orcid.org/0000-0002-5404-1268)
- Rubing Liang (ORCID: https://orcid.org/0009-0001-2914-0002)
- Zhoutong Sun (ORCID: https://orcid.org/0000-0002-9923-0951)
- Qingxin Wu
- Shuai Wei (ORCID: https://orcid.org/0000-0003-3051-2480)
- Qiqi Zhang (ORCID: https://orcid.org/0000-0002-6564-3256)
- Qian Liu (ORCID: https://orcid.org/0000-0003-3876-4877)
- Long Zhang (ORCID: https://orcid.org/0000-0001-8139-0474)
- Lijie Liu (ORCID: https://orcid.org/0000-0002-6654-6108)
- Zhining Liu (ORCID: https://orcid.org/0000-0002-2723-5999)
- Jiahao An
- Lirong Lu
Institutions
- Sun Yat-sen University (CN)
- Kingmed Diagnostics (CN)
- University of South China (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-11
- DOI
- https://doi.org/10.3389/fimmu.2025.1574568
- Citations
- 2
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- State Key Laboratory of Respiratory Disease